1. Richard Flemming Richard Flemming United States says:

    To try to diminish the health value of Resveratrol based on one small scale, non placebo controlled, now double blinded trial of a wine that is not even known for having significant amounts of Resveratrol in it is pandering to the big pharmas who own or virtually own the media.   A simple scholar google search will return over 100,000 studies, papers and investigations, including well designed human clinical trials which contradict this one study which was far too small to be meaningful, not double blinded, not placebo controlled, not randomised, and whose premise was flawed. One would not expect to find the metabolites of Resveratrol in the urine of wine drinkers.  The sulphated and glucoronated forms of this compound have a half life of literally 12 minutes.  It appears that big pharma is still determined to push their attack on resveratrol.  Why this one very weak and hardly compelling study was given any press at all is the question when it is contradicted by literally thousands of far better designed, properly run, scientific studies. This study was funded by big pharma. What do you expect in terms of conclusions? It is irresponsible of this news media to publish it out of context ,and without mentioning the thousands of other studies that contradict it.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.